XML 123 R15.htm IDEA: XBRL DOCUMENT
v3.20.1

Intellectual Property | 6 Months Ended | 12 Months Ended
--- | --- | ---
Feb. 29, 2020 | Aug. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract] |  |
Intellectual Property | 9. Intellectual Property The following is a list of US capitalized patents held by the Company
Issued Patent # | Patent Issuance Date | Patent Family
US 9,474,725 B1 | 10/25/2016 | Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof
US 9,839,612 B2 | 12/12/2017
US 9,972,680 B2 | 05/15/2018
US 9,974,739 B2 | 05/22/2018
US 10,084,044 B2 | 09/25/2018
US 10,103,225 B2 | 10/16/2018
US 10,381,440 | 08/13/2019
US 10,374,036 | 08/06/2019
The Company also holds non-capitalized patents outside the US. A continuity schedule for capitalized patents is presented below:
|  | February 29 |  |  | August 31 |
|  | 2020 |  |  | 2019 |
|  | $ |  |  | $ |
Balance – beginning |  |  | 265,127 |  |  |  | 146,538 |
Addition |  |  | 5,711 |  |  |  | 122,982 |
Amortization* |  |  | (2,843 | ) |  |  | (4,393 | )
Balance – ending |  |  | 267,995 |  |  |  | 265,127 |
*The patents are amortized over their legal life of 20 years. |  |  |  |  |  |  |  |
9. | Intellectual Property
| On November 12, 2014, the Company signed an agreement with Poppy’s Teas LLC. whereby it acquired a 51% interest. Subsequent to signing the agreement, Poppy’s Teas LLC effected a name change to PoViva Tea LLC. The Company acquired the remaining 49% ownership interest in PoViva Tea, LLC in October 2017 via compensation of $70,000, a waiver on certain debts owed to Lexaria, and a 5%, 20-year royalty on net profits of ViPova TeaTM tea, coffee, and hot chocolate sales. No Lexaria stock or options were issued. On September 18, 2018 Poviva Tea, LLC converted from a Nevada limited liability company to a Nevada corporation and effected a name change to Poviva Corp.
| The following is a list of US capitalized patents held by the Company
Issued Patent # | Patent Issuance Date | Patent Family
US 9,474,725 B1 | 10/25/2016 | Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof
US 9,839,612 B2 | 12/12/2017
US 9,972,680 B2 | 05/15/2018
US 9,974,739 B2 | 05/22/2018
US 10,084,044 B2 | 09/25/2018
US 10,103,225 B2 | 10/16/2018
US 10,381,440 | 08/13/2019
US 10,374,036 | 08/06/2019
| The Company also holds non-capitalized patents outside the US. A continuity schedule for patents is presented below:
|  | August 31 |  |  | August 31 |
|  | 2019 |  |  | 2018 |
|  | $ |  |  | $ |
Balance – Beginning |  |  | 146,538 |  |  |  | 62,827 |
Addition |  |  | 122,982 |  |  |  | 85,399 |
Amortization* |  |  | (4,393 | ) |  |  | (1,688 | )
Balance – Ending |  |  | 265,127 |  |  |  | 146,538 |
* The patents are amortized over their legal life of 20 years.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration